Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Familial cardiomyopathy
PRKAG2-related cardiomyopathy
A metabolic heart condition characterized by variable cardiac hypertrophy, ventricular pre-excitation, and aberrant glycogen storage in the cardiac tissue due to a pathogenic variant in PRKAG2 that results in a net anabolic effect in cardiac cells.
-
Wolff-Parkinson-White syndrome 3 trials
-
Hypertrophic cardiomyopathy 6 0 trials